{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:44:22Z","timestamp":1792532662593,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4040124"],"award-info":[{"award-number":["4040124"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasite Epidemiology and Control"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.parepi.2026.e00478","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:30:22Z","timestamp":1770312622000},"page":"e00478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A 10-year registry-based retrospective study of cutaneous Leishmaniasis in Mashhad, northeastern Iran: Demographic, clinical, and therapeutic profiles of 1537 cases"],"prefix":"10.1016","volume":"33","author":[{"given":"Vahid","family":"Mashayekhi-Goyonlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouran","family":"Layegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masomeh","family":"Hosseini-Nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010271","article-title":"Fifty years of struggle to control cutaneous leishmaniasis in the highest endemic county in Iran: a longitudinal observation inferred with interrupted time series model","volume":"16","author":"Aflatoonian","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.parepi.2026.e00478_bb0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.26719\/2013.19.10.847","article-title":"First survey of cutaneous leishmaniasis in Borujerd county, western Islamic Republic of Iran","volume":"19","author":"Ahmadi","year":"2013","journal-title":"East Mediterr. Health J."},{"issue":"12","key":"10.1016\/j.parepi.2026.e00478_bb0015","article-title":"Cutaneous leishmaniasis prevalence and clinical overview: a single center study from Saudi Arabia, eastern region, Al-Ahsa","volume":"8","author":"Al-Dhafiri","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0020","doi-asserted-by":"crossref","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20180136","article-title":"A clinico-epidemiological study on cutaneous leishmaniasis in Erbil, Iraq (2015\u20132017)","volume":"4","author":"Al-Khayat","year":"2018","journal-title":"Int. J. Res. Dermatol."},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001700","article-title":"First molecular epidemiological study of cutaneous leishmaniasis in Libya","volume":"6","author":"Amro","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.parepi.2026.e00478_bb0030","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-017-0224-y","article-title":"Parasitological and biochemical studies on cutaneous leishmaniasis in Shara\u2019b district, Taiz, Yemen","volume":"16","author":"Asmaa","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"2","key":"10.1016\/j.parepi.2026.e00478_bb0040","first-page":"153","article-title":"A history of Leishmaniasis in Iran from 19th century onward","volume":"19","author":"Azizi","year":"2016","journal-title":"Arch. Iran. Med."},{"issue":"9","key":"10.1016\/j.parepi.2026.e00478_bb0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.12980\/apjtd.7.2017D6-452","article-title":"The burden of leishmaniasis in Iran, acquired from the global burden of disease during 1990\u20132010","volume":"7","author":"Badirzadeh","year":"2017","journal-title":"Asian Pac. J. Trop. Dis."},{"key":"10.1016\/j.parepi.2026.e00478_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.638957","article-title":"Determinants of unresponsiveness to treatment in cutaneous Leishmaniasis: a focus on Anthroponotic form due to Leishmania tropica","volume":"12","author":"Bamorovat","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.parepi.2026.e00478_bb0055","doi-asserted-by":"crossref","unstructured":"Bamorovat M, Sharifi I, Agha Kuchak Afshari S, Karamoozian A, Tahmouresi A, Heshmatkhah A, et al. Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: a case-control field assessment in Iran. Int. J. Parasitol. Drugs Drug Resist. 2023;21:21\u201327. eng. [PubMed ID:36525935]. [PubMed Central ID:PMC9791244]. doi:https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.006.","DOI":"10.1016\/j.ijpddr.2022.11.006"},{"key":"10.1016\/j.parepi.2026.e00478_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.993338","article-title":"Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: a retrospective cohort study from a Leishmania braziliensis-endemic area","volume":"12","author":"Barroso","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.parepi.2026.e00478_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008507","article-title":"Clinical, parasitological and molecular profiles of cutaneous leishmaniasis and its associated factors among clinically suspected patients attending Borumeda hospital, north-East Ethiopia","volume":"14","author":"Bisetegn","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parepi.2026.e00478_bb0070","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946201759033","article-title":"Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro state, Brazil","volume":"59","author":"Carvalho","year":"2017","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005515","article-title":"Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study","volume":"11","author":"Castro","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011029","article-title":"Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: a collaborative retrospective study","volume":"17","author":"Castro","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7","key":"10.1016\/j.parepi.2026.e00478_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad348","article-title":"Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal Leishmaniasis: a systematic review and meta-analysis","volume":"10","author":"Chivinski","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.parepi.2026.e00478_bb0090","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous Leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"issue":"5","key":"10.1016\/j.parepi.2026.e00478_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/jgid.jgid_16_17","article-title":"Epidemiological trends of cutaneous Leishmaniasis in Al-Madinah Al-Munawarah Province, Western region of Saudi Arabia","volume":"9","author":"Elmekki","year":"2017","journal-title":"J. Global Infect. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3347\/kjp.2017.55.1.1","article-title":"Clinico-epidemiological patterns of cutaneous Leishmaniasis patients attending the Anuradhapura teaching hospital, Sri Lanka","volume":"55","author":"Galgamuwa","year":"2017","journal-title":"Korean J. Parasitol."},{"issue":"10","key":"10.1016\/j.parepi.2026.e00478_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186117","article-title":"Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis","volume":"12","author":"Galv\u00e3o","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.parepi.2026.e00478_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00011","article-title":"The geographical distribution of cutaneous Leishmaniasis causative agents in Iran and its neighboring countries, a review","volume":"8","author":"Ghatee","year":"2020","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12879-018-3539-1","article-title":"Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes","volume":"18","author":"Glans","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00478_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijid.2022.06.025","article-title":"Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019","volume":"122","author":"Glans","year":"2022","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4103\/0019-5154.143571","article-title":"Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis","volume":"59","author":"Goyonlo","year":"2014","journal-title":"Indian J. Dermatol."},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0140","doi-asserted-by":"crossref","first-page":"e0011358","DOI":"10.1371\/journal.pntd.0011358","article-title":"The leishmaniases in Kenya: a scoping review","volume":"17","author":"Grifferty","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.parepi.2026.e00478_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009863","article-title":"Clinical diversity and treatment results in Tegumentary Leishmaniasis: a European clinical report in 459 patients","volume":"15","author":"Guery","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parepi.2026.e00478_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actatropica.2016.11.004","article-title":"Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013","volume":"166","author":"Holakouie-Naieni","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.parepi.2026.e00478_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-2999-7","article-title":"Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka","volume":"18","author":"Iddawela","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0972-9062.112532","article-title":"Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran","volume":"50","author":"Karami","year":"2013","journal-title":"J. Vector Borne Dis."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-021-04619-3","article-title":"A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor","volume":"14","author":"Karimi","year":"2021","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.parepi.2026.e00478_bb0170","first-page":"237","article-title":"Molecular identification of leishmania species causing cutaneous Leishmaniasis in Mashhad area, Iran","volume":"21","author":"Karimian Shirazi","year":"2014","journal-title":"J.Transl. Med. Res."},{"key":"10.1016\/j.parepi.2026.e00478_bb0175","doi-asserted-by":"crossref","unstructured":"Khazaei SU, Mohammadian Hafshejani AU, Saatchi MU, Salehiniya HU, Nematollahi SU. Arch. Clin. Infect. Dis.:e28511. doi:https:\/\/doi.org\/10.5812\/archcid.28511.","DOI":"10.5812\/archcid.28511"},{"issue":"2","key":"10.1016\/j.parepi.2026.e00478_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0738-081X(99)00006-1","article-title":"Cutaneous leishmaniasis in the Middle East","volume":"17","author":"Klaus","year":"1999","journal-title":"Clin. Dermatol."},{"issue":"11","key":"10.1016\/j.parepi.2026.e00478_bb0185","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ijd.16278","article-title":"Erysipeloid cutaneous leishmaniasis: a study of 40 cases of an unusual variant","volume":"61","author":"Kouki","year":"2022","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4269\/ajtmh.2007.77.99","article-title":"Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"77","author":"Layegh","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parepi.2026.e00478_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/656523","article-title":"Efficacy of topical liposomal amphotericin B versus intralesional meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"2011","author":"Layegh","year":"2011","journal-title":"J. Parasitol. Res."},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0200","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/cid\/civ416","article-title":"Treatment of disseminated Leishmaniasis with liposomal amphotericin B","volume":"61","author":"Machado","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.parepi.2026.e00478_bb0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of cutaneous Leishmaniasis and insights into species-specific responses: a narrative review","volume":"11","author":"Madusanka","year":"2022","journal-title":"Infect. Dis. Ther."},{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0210","first-page":"195","article-title":"Molecular identification of Leishmania species causing cutaneous leishmaniasis in Mashhad, Iran","volume":"3","author":"Mahmoodi","year":"2010","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.parepi.2026.e00478_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthplace.2024.103394","article-title":"Spatial modelling to identify high-risk zones for the transmission of cutaneous leishmaniasis in hyperendemic urban environments: a case study of Mashhad, Iran","volume":"91","author":"Mohammadi","year":"2025","journal-title":"Health Place"},{"issue":"6","key":"10.1016\/j.parepi.2026.e00478_bb0220","first-page":"701","article-title":"Azithromycin is not effective in the treatment of old world cutaneous leishmaniasis","volume":"16","author":"Momeni","year":"2006","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.parepi.2026.e00478_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0365-05962011000100007","article-title":"American cutaneous leishmaniasis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil","volume":"86","author":"Murback","year":"2011","journal-title":"An. Bras. Dermatol."},{"issue":"12","key":"10.1016\/j.parepi.2026.e00478_bb0230","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1016\/j.ijid.2013.07.003","article-title":"A newly emerged cutaneous leishmaniasis focus in Central Iran","volume":"17","author":"Nateghi Rostami","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.parepi.2026.e00478_bb0235","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.apjtb.2016.05.005","article-title":"Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces","volume":"6","author":"Norouzinezhad","year":"2016","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"Supple 1","key":"10.1016\/j.parepi.2026.e00478_bb0240","first-page":"28","article-title":"Incidence, burden, and trend of cutaneous leishmaniasis over four decades in Iran","volume":"48","author":"Piroozi","year":"2019","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.parepi.2026.e00478_bb0245","doi-asserted-by":"crossref","unstructured":"Prata A, Silva-Vergara ML, Costa L, Rocha A, Krolewiecki A, Silva JC, et al. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. Rev. Soc. Bras. Med. Trop. 2003;36(1):65\u201369. eng. [PubMed ID:12715065]. doi:https:\/\/doi.org\/10.1590\/s0037-86822003000100010.","DOI":"10.1590\/S0037-86822003000100010"},{"key":"10.1016\/j.parepi.2026.e00478_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/jotm\/7537793","article-title":"Investigating the effects of demographic factors on the prevalence of cutaneous leishmaniasis in a focus area of northeastern Iran","volume":"2025","author":"Rajabi Gharaii","year":"2025","journal-title":"J. Trop. Med."},{"issue":"9","key":"10.1016\/j.parepi.2026.e00478_bb0255","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.386","article-title":"The overall impact of COVID-19 on healthcare during the pandemic: a multidisciplinary point of view","volume":"4","author":"Sabetkish","year":"2021","journal-title":"Health Sci. Rep."},{"issue":"10","key":"10.1016\/j.parepi.2026.e00478_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the middle east: incidence and epidemiology","volume":"8","author":"Salam","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.parepi.2026.e00478_bb0270","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/0972-9062.374236","article-title":"Environmental health risk factors and cutaneous leishmaniasis (CL): a case-control study in northeastern Iran","volume":"60","author":"Sarmadi","year":"2023","journal-title":"J. Vector Borne Dis."},{"issue":"8","key":"10.1016\/j.parepi.2026.e00478_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1489","volume":"6","author":"Shams","year":"2023","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.parepi.2026.e00478_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1091709","article-title":"Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan","volume":"11","author":"Sharifi","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.parepi.2026.e00478_bb0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.actatropica.2016.08.020","article-title":"Canine visceral leishmaniasis in Iran: a systematic review and meta-analysis","volume":"165","author":"Shokri","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.parepi.2026.e00478_bb0290","doi-asserted-by":"crossref","first-page":"adv00721","DOI":"10.2340\/actadv.v102.2079","article-title":"Efficacy of systemic treatment for Leishmania tropica cutaneous Leishmaniasis","volume":"102","author":"Solomon","year":"2022","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.parepi.2026.e00478_bb0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis","volume":"47","author":"Tuon","year":"2008","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"10.1016\/j.parepi.2026.e00478_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009460","article-title":"Miltefosine for the treatment of cutaneous leishmaniasis-a pilot study from Ethiopia","volume":"15","author":"van Henten","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7","key":"10.1016\/j.parepi.2026.e00478_bb0305","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1093\/cid\/ciaa1238","article-title":"Efficacy and tolerability of Miltefosine in the treatment of cutaneous Leishmaniasis","volume":"73","author":"Ware","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00478_bb0310","series-title":"Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.parepi.2026.e00478_bb0315","author":"World Health Organization"},{"key":"10.1016\/j.parepi.2026.e00478_bb0320","author":"World Health Organization"},{"key":"10.1016\/j.parepi.2026.e00478_bb0325","series-title":"Lancet Infect Dis","first-page":"303","article-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"Zumla","year":"2010"}],"container-title":["Parasite Epidemiology and Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673126000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673126000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:34:34Z","timestamp":1784849674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405673126000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":65,"alternative-id":["S2405673126000036"],"URL":"https:\/\/doi.org\/10.1016\/j.parepi.2026.e00478","relation":{},"ISSN":["2405-6731"],"issn-type":[{"value":"2405-6731","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 10-year registry-based retrospective study of cutaneous Leishmaniasis in Mashhad, northeastern Iran: Demographic, clinical, and therapeutic profiles of 1537 cases","name":"articletitle","label":"Article Title"},{"value":"Parasite Epidemiology and Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parepi.2026.e00478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.","name":"copyright","label":"Copyright"}],"article-number":"e00478"}}